Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy
Purpose To compare the efficacy and safety of intravitreal aflibercept (IVA) monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) (IVA+RF-PDT) for the treatment of polypoidal choroidal vasculopathy (PCV).Methods and analysis Multicentred, double-masked, randomis...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
BMJ Publishing Group
2021-07-01
|
Serier: | BMJ Open |
Online adgang: | https://bmjopen.bmj.com/content/11/7/e050252.full |